Monday, 10 August 2020


GBC develops novel molecular testing kit for COVID-19

09 July 2020 | News

GBC's PCR Kit allows one-step real-time testing with results available within 1.5-2 hours

Image credit- shutterstock.com

Image credit- shutterstock.com

General Biologicals Corporation (GBC), a Taiwanese medical device company has developed the GB SARS-CoV-2 Real-Time RT-PCR (PCR Kit): a reliable molecular testing kit for the detection of the novel coronavirus in humans.

This comes amid the continued global battle against COVID-19 and demand for accurate testing remains at an all-time high, particularly in affected countries such as the US.

GBC's PCR Kit allows one-step real-time testing with results available within 1.5-2 hours. 

In addition to its PCR Kit, GBC is currently developing other COVID-19 testing solutions including a SARS-CoV-2 antigen test and antibody test. 

The antigen test is a rapid diagnostic test that detects specific proteins on the surface of the virus via a nasal or throat swab. Results are available in 10 to 15 minutes.

GBC is also developing a total antibody ELISA test, a serological test that detects Immunoglobulin M (IgM) and Immunoglobulin G (IgG) to determine the presence of SARS-CoV-2 in patients. Antibody tests can reveal if a patient has had COVID-19 and has built up an immune response but cannot be used to diagnose an active infection.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls